DecisionPoint Financial’s Novo Nordisk NVO Stock Holding History

DecisionPoint Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.43K	Hold	66	–	–	﹤0.01%	267
2025 Q4	$3.36K	Hold	66	–	–	﹤0.01%	291
2025 Q3	$3.91K	Hold	66	–	–	﹤0.01%	189
2025 Q2	$4.61K	Hold	66	–	–	﹤0.01%	184
2025 Q1	$4.58K	Hold	66	–	–	﹤0.01%	182
2024 Q4	$5.68K	Hold	66	–	–	﹤0.01%	187
2024 Q3	$7.86K	Hold	66	–	–	﹤0.01%	171
2024 Q2	$8.75K	Hold	66	–	–	﹤0.01%	158
2024 Q1	$8.37K	Hold	66	–	–	﹤0.01%	168
2023 Q4	$6.83K	Buy	66 +30	+83%	+$2.97K	﹤0.01%	145
2023 Q3	$3.27K	Hold	36	–	–	﹤0.01%	168
2023 Q2	$2.91K	Hold	36	–	–	﹤0.01%	156
2023 Q1	$2.87K	Hold	36	–	–	﹤0.01%	159
2022 Q4	$2.44K	Buy	+36	New	+$2.11K	﹤0.01%	140

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

DecisionPoint Financial's NVO Position: Q1 2026 in Review

DecisionPoint Financial held its Novo Nordisk (NVO) position steady in Q1 2026 at 66 shares worth $2.43K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

DecisionPoint Financial first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.75K in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

DecisionPoint Financial held 66 shares of Novo Nordisk worth $2.43K as of Q1 2026.
DecisionPoint Financial left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up ﹤0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #267 holding.
DecisionPoint Financial first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
DecisionPoint Financial's Novo Nordisk position peaked at $8.75K in Q2 2024.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.